Literature DB >> 24002920

Mechanistic insights into isoform-dependent and species-specific regulation of bile salt export pump by farnesoid X receptor.

Xiulong Song1, Yuan Chen, Leila Valanejad, Rajani Kaimal, Bingfang Yan, Matthew Stoner, Ruitang Deng.   

Abstract

Expression of bile salt export pump (BSEP) is regulated by the bile acid/farnesoid X receptor (FXR) signaling pathway. Two FXR isoforms, FXRα1 and FXRα2, are predominantly expressed in human liver. We previously showed that human BSEP was isoform-dependently regulated by FXR and diminished with altered expression of FXRα1 and FXRα2 in patients with hepatocellular carcinoma. In this study, we demonstrate that FXRα1 and FXRα2 regulate human BSEP through two distinct FXR responsive elements (FXRE): IR1a and IR1b. As the predominant regulator, FXRα2 potently transactivated human BSEP through IR1a, while FXRα1 weakly transactivated human BSEP through a newly identified IR1b. Relative expression of FXRα1 and FXRα2 affected human BSEP expression in vitro and in vivo. Electrophoretic mobility shift and chromatin immunoprecipitation assays confirmed the binding and recruitment of FXRα1 and FXRα2 to IR1b and IR1a. Sequence analysis concluded that IR1b was completely conserved among species, whereas IR1a exhibited apparent differences across species. Sequence variations in IR1a were responsible for the observed species difference in BSEP transactivation by FXRα1 and FXRα2. In conclusion, FXR regulates BSEP in an isoform-dependent and species-specific manner through two distinct FXREs, and alteration of relative FXR isoform expression may be a potential mechanism for FXR to precisely regulate human BSEP in response to various physiological and pathological conditions.

Entities:  

Keywords:  bile acid transporter; canalicular secretion; gene transcription

Mesh:

Substances:

Year:  2013        PMID: 24002920      PMCID: PMC3793607          DOI: 10.1194/jlr.M038323

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  40 in total

1.  Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor.

Authors:  Ruitang Deng; Dongfang Yang; Jian Yang; Bingfang Yan
Journal:  J Pharmacol Exp Ther       Date:  2005-12-21       Impact factor: 4.030

2.  Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency.

Authors:  A S Knisely; Sandra S Strautnieks; Yvonne Meier; Bruno Stieger; Jane A Byrne; Bernard C Portmann; Laura N Bull; Ludmila Pawlikowska; Banu Bilezikçi; Figen Ozçay; Aranka László; László Tiszlavicz; Lynette Moore; Jeremy Raftos; Henrik Arnell; Björn Fischler; Antal Németh; Nikos Papadogiannakis; Joanna Cielecka-Kuszyk; Irena Jankowska; Joanna Pawłowska; Hector Melín-Aldana; Karan M Emerick; Peter F Whitington; Giorgina Mieli-Vergani; Richard J Thompson
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

3.  Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy.

Authors:  Verena Keitel; Christoph Vogt; Dieter Häussinger; Ralf Kubitz
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

4.  Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury.

Authors:  Carmen Lang; Yvonne Meier; Bruno Stieger; Ulrich Beuers; Thomas Lang; Reinhold Kerb; Gerd A Kullak-Ublick; Peter J Meier; Christiane Pauli-Magnus
Journal:  Pharmacogenet Genomics       Date:  2007-01       Impact factor: 2.089

5.  The hypolipidemic agent guggulsterone regulates the expression of human bile salt export pump: dominance of transactivation over farsenoid X receptor-mediated antagonism.

Authors:  Ruitang Deng; Dongfang Yang; Amy Radke; Jian Yang; Bingfang Yan
Journal:  J Pharmacol Exp Ther       Date:  2006-11-29       Impact factor: 4.030

6.  Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1.

Authors:  Hansook Kim Chong; Aniello M Infante; Young-Kyo Seo; Tae-Il Jeon; Yanqiao Zhang; Peter A Edwards; Xiaohui Xie; Timothy F Osborne
Journal:  Nucleic Acids Res       Date:  2010-05-18       Impact factor: 16.971

7.  Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.

Authors:  Fan Yang; Xiongfei Huang; Tangsheng Yi; Yun Yen; David D Moore; Wendong Huang
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

8.  Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma.

Authors:  Yuan Chen; Xiulong Song; Leila Valanejad; Alexander Vasilenko; Vijay More; Xi Qiu; Weikang Chen; Yurong Lai; Angela Slitt; Matthew Stoner; Bingfang Yan; Ruitang Deng
Journal:  Hepatology       Date:  2013-02-15       Impact factor: 17.425

9.  Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine.

Authors:  Ann M Thomas; Steven N Hart; Bo Kong; Jianwen Fang; Xiao-Bo Zhong; Grace L Guo
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

10.  Nuclear factor erythroid 2-related factor 2 is a positive regulator of human bile salt export pump expression.

Authors:  Jittima Weerachayaphorn; Shi-Ying Cai; Carol J Soroka; James L Boyer
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

View more
  14 in total

1.  Quantification of common and planar bile acids in tissues and cultured cells.

Authors:  Stephanie J Shiffka; Jace W Jones; Linhao Li; Ann M Farese; Thomas J MacVittie; Hongbing Wang; Peter W Swaan; Maureen A Kane
Journal:  J Lipid Res       Date:  2020-07-22       Impact factor: 5.922

2.  Hepatic Autophagy Deficiency Compromises Farnesoid X Receptor Functionality and Causes Cholestatic Injury.

Authors:  Bilon Khambu; Tiangang Li; Shengmin Yan; Changshun Yu; Xiaoyun Chen; Michael Goheen; Yong Li; Jingmei Lin; Oscar W Cummings; Youngmin A Lee; Scott Friedman; Zheng Dong; Gen-Sheng Feng; Shangwei Wu; Xiao-Ming Yin
Journal:  Hepatology       Date:  2019-03-08       Impact factor: 17.425

3.  Estrogen and Estrogen Receptor-α-Mediated Transrepression of Bile Salt Export Pump.

Authors:  Yuan Chen; Alex Vasilenko; Xiulong Song; Leila Valanejad; Ruchi Verma; Sangmin You; Bingfang Yan; Stephanie Shiffka; Leeza Hargreaves; Christina Nadolny; Ruitang Deng
Journal:  Mol Endocrinol       Date:  2015-02-12

Review 4.  Nuclear bile acid signaling through the farnesoid X receptor.

Authors:  Claire Mazuy; Audrey Helleboid; Bart Staels; Philippe Lefebvre
Journal:  Cell Mol Life Sci       Date:  2014-12-16       Impact factor: 9.261

5.  Baohuoside I inhibits FXR signaling pathway to interfere with bile acid homeostasis via targeting ER α degradation.

Authors:  Zhen Zhao; Lu-Lu Yang; Qiao-Lei Wang; Jin-Fa Du; Zu-Guo Zheng; Yan Jiang; Ping Li; Hui-Jun Li
Journal:  Cell Biol Toxicol       Date:  2022-07-08       Impact factor: 6.691

Review 6.  Enterohepatic and non-canonical roles of farnesoid X receptor in controlling lipid and glucose metabolism.

Authors:  Weinan Zhou; Sayeepriyadarshini Anakk
Journal:  Mol Cell Endocrinol       Date:  2022-03-15       Impact factor: 4.369

7.  Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepatic cholestasis of pregnancy.

Authors:  Xiulong Song; Alexander Vasilenko; Yuan Chen; Leila Valanejad; Ruchi Verma; Bingfang Yan; Ruitang Deng
Journal:  Hepatology       Date:  2014-05-19       Impact factor: 17.425

8.  Metformin Disrupts Bile Acid Efflux by Repressing Bile Salt Export Pump Expression.

Authors:  Brandy Garzel; Tao Hu; Linhao Li; Yuanfu Lu; Scott Heyward; James Polli; Lei Zhang; Shiew-Mei Huang; Jean-Pierre Raufman; Hongbing Wang
Journal:  Pharm Res       Date:  2020-01-06       Impact factor: 4.200

9.  Dysregulation of Δ4-3-oxosteroid 5β-reductase in diabetic patients: Implications and mechanisms.

Authors:  Leila Valanejad; Mwlod Ghareeb; Stephanie Shiffka; Christina Nadolny; Yuan Chen; Liangran Guo; Ruchi Verma; Sangmin You; Fatemeh Akhlaghi; Ruitang Deng
Journal:  Mol Cell Endocrinol       Date:  2017-10-09       Impact factor: 4.102

10.  Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism.

Authors:  Jorge C Correia; Julie Massart; Jan Freark de Boer; Margareta Porsmyr-Palmertz; Vicente Martínez-Redondo; Leandro Z Agudelo; Indranil Sinha; David Meierhofer; Vera Ribeiro; Marie Björnholm; Sascha Sauer; Karin Dahlman-Wright; Juleen R Zierath; Albert K Groen; Jorge L Ruas
Journal:  Mol Metab       Date:  2015-09-26       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.